Marshall Wace North America’s NuVasive, Inc. NUVA Stock Holding History

Marshall Wace North America’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,943	Closed	-$187K	–	1690
2019 Q3	$187K	Sell	2,943 -4,880	-62%	-$305K	﹤0.01%	971
2019 Q2	$458K	Buy	+7,823	New	+$462K	﹤0.01%	905
2019 Q1	–	Sell	-23,520	Closed	-$1.17M	–	1992
2018 Q4	$1.17M	Buy	+23,520	New	+$1.41M	0.01%	577
2018 Q3	–	Sell	-291,002	Closed	-$15.2M	–	1477
2018 Q2	$15.2M	Sell	291,002 -547,976	-65%	-$28.7M	0.09%	253
2018 Q1	$43.8M	Sell	838,978 -253,693	-23%	-$12.9M	0.22%	107
2017 Q4	$63.9M	Buy	1,092,671 +330,083	+43%	+$18.7M	0.35%	61
2017 Q3	$41.9M	Buy	+762,588	New	+$50.5M	0.27%	88

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace North America's NUVA Position: Q4 2019 in Review

Marshall Wace North America sold out of NuVasive, Inc. (NUVA) in Q4 2019, closing a stake of 2,943 shares — an estimated $187K sold.

Marshall Wace North America first reported a position in NUVA in Q3 2017 and held it in 7 quarters. The position peaked at $63.9M in Q4 2017. 290 funds tracked by Wall St. Rank hold NUVA as of Q4 2019.

Marshall Wace North America reported no remaining NuVasive, Inc. position as of Q4 2019 after selling out during the quarter.
Marshall Wace North America sold 2,943 NuVasive, Inc. shares in Q4 2019, an estimated $187K.
Marshall Wace North America first reported a position in NuVasive, Inc. in Q3 2017 and held it in 7 quarters.
Marshall Wace North America's NuVasive, Inc. position peaked at $63.9M in Q4 2017.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.